The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers

Acute lymphoblastic leukemia (ALL) and Chronic lymphocytic leukemia (CLL) are the most common leukemias in children and elderly people, respectively. Standard therapies, such as chemotherapy, are only effective in 40% of ALL adult patients with a five-year survival rate and therefore new alternative...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan, Cristina Eguizabal
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/4ba5c4420bbb41e9b71bdae59fe70e56
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!